AdAlta $0.024
(0.00%)
|
High $0.03 |
Low $0.02 |
Trades 24 |
Turnover $54,432 |
Volume 2,170,184 |
| 30 June 2023 at 3:59pm | ||||
ADALTA LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Nov) $8,030,422 (1,598th) |
Close (30-Jun) $0.024 |
Volume (30-Jun) 2,170,184 |
Shortsold (2-Feb) 3,141 (0.00%) (662nd) |
|
52w High $0.008 |
52w Low $0.002 |
P/E - |
EPS 0 |
Appendix 4G and Corporate Governance Statement
1AD released this announcement to the ASX on 29 August 2022, 9:33. The announcement is not marked as price sensitive, and is 30 page(s) in length and 609.33kb in size.
You can view all announcements from 1AD and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from 1AD | |
|---|---|
| AD-214 clinical trial approval | 29 June 2023, 8:21 |
| Change in substantial holding | 31 May 2023, 13:30 |
| Change in substantial holding | 31 May 2023, 9:34 |
| Appendix 4G and Corporate Governance Statement | 29 August 2022, 9:33 |
| Annual Report to shareholders | 29 August 2022, 9:12 |
| Preliminary Final Report | 29 August 2022, 9:11 |
| Sydney Investor Briefing Invitation | 8 August 2022, 11:10 |
If you were already registered, log in here.
If you were already registered, log in here.